MAXIA PHARMACEUTICALS INC has a total of 25 patent applications. Its first patent ever was published in 2000. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Canada. Its main competitors in its focus markets organic fine chemistry and pharmaceuticals are FABRICA ESPANOLA DE PRODUCTOS QUIM Y FARMACEUTICOS S A FAES, CONVERGENE LLC and GUANGZHOU BAIYUNSHAN PHARMACEU.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 7 | |
#2 | Australia | 5 | |
#3 | Canada | 2 | |
#4 | South Africa | 2 | |
#5 | Argentina | 1 | |
#6 | Brazil | 1 | |
#7 | China | 1 | |
#8 | EPO (European Patent Office) | 1 | |
#9 | Israel | 1 | |
#10 | Mexico | 1 | |
#11 | Taiwan | 1 | |
#12 | Ukraine | 1 | |
#13 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Tachdjian Catherine | 20 |
#2 | Pfahl Magnus | 20 |
#3 | Spruce Lyle W | 18 |
#4 | Al-Shamma Hussien A | 14 |
#5 | Pleynet David P M | 12 |
#6 | Fanjul Andrea | 10 |
#7 | Pleynet David P N | 7 |
#8 | Al-Shamma Hussein A | 7 |
#9 | Wiemann Torsten R | 6 |
#10 | Fanjul Andrea N | 5 |
Publication | Filing date | Title |
---|---|---|
TW200304375A | 2-Substituted thiazolidinone and oxazolidinone derivatives for the inhibition of phosphatases and the treatment of cancer | |
WO02072009A2 | Heterocyclic derivatives for the treatment of cancer and other proliferative diseases | |
AU6949900A | Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes |